Cargando…

MGCD0103 induces apoptosis and simultaneously increases the expression of NF-κB and PD-L1 in classical Hodgkin's lymphoma

At present there is no consensus on the treatment of classical Hodgkin's lymphoma (CHL) following relapse. The aim of the present study was to access the class I-selective histone deacetylase (HDAC) inhibitor (HDACI) MGCD0103 on the expression levels of Bcl-2, nuclear factor (NF)-κB and program...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Renhong, Zhang, Xiaowei, Min, Zhijun, Shadia, Abdelbari Sophia, Yang, Shun'e, Liu, Xiaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176203/ https://www.ncbi.nlm.nih.gov/pubmed/30344659 http://dx.doi.org/10.3892/etm.2018.6677

Ejemplares similares

The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method
por: Cai, Jinzhang, et al.
Publicado: (2015)

Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest, apoptosis, and autophagy in liver cancer cells
por: Liao, Bo, et al.
Publicado: (2020)

Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia
por: El-Khoury, V, et al.
Publicado: (2014)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting
por: Kaya Çakir, Hacer, et al.
Publicado: (2021)

MGCD0103, a selective histone deacetylase inhibitor, coameliorates oligomeric Aβ(25‐35)‐induced anxiety and cognitive deficits in a mouse model
por: Huang, Hei‐Jen, et al.
Publicado: (2018)

The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling
por: Sikandar, Shaheen, et al.
Publicado: (2010)

PA01.03. Rural health and snakebite
por: Dutta, Arun Kumar, et al.
Publicado: (2012)

PROJECT ADMINISTRATION AGREEMENT ICA-JP-0103-TSUKUBA
por: The European Organization for Nuclear Reserch, Cern, et al.
Publicado: (2008)

P01.03. A machine classification measure of meditation ability
por: McCollough, A, et al.
Publicado: (2012)

EHMTI-0103. Errors in recognition and management are still frequent in cluster headache
por: del Río, M Sánchez, et al.
Publicado: (2014)

OA01.03. Emergency management of pakshaghata - A case study
por: Shankar, Prasan
Publicado: (2013)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
por: Wang, Yucai, et al.
Publicado: (2018)

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
por: Hollander, Peter, et al.
Publicado: (2018)

OA01.03. Antisecretory and antiulcer activities of eclipta alba Linn.in rats
por: Samaiya, Puneet Kumar, et al.
Publicado: (2012)

Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin’s lymphoma
por: Feng, Xia, et al.
Publicado: (2023)

The approval of sintilimab for classical Hodgkin's lymphoma: views and perspectives of anti-PD-1/PD-L1 antibodies in China
por: Deng, Mi
Publicado: (2019)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression
por: Koh, Young Wha, et al.
Publicado: (2017)

PD‐L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2022)

P01.03. It Takes HEART: A Multifaceted Weight-loss Program for People Living With HIV
por: Gandhi, Vani, et al.
Publicado: (2013)

CP01.03 COVID 19’s Pandemic’s Effect on a Community Lung Cancer Screening Program
por: Gieske, M., et al.
Publicado: (2021)

Complete Genome Sequence of a Suckermouth Catfish Outbreak Isolate, Aeromonas hydrophila Strain LP0103
por: Bureros, Kenneth Joseph, et al.
Publicado: (2022)

High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma
por: Chen, Xi, et al.
Publicado: (2022)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

The Grey Zones of Classic Hodgkin Lymphoma
por: Bosch-Schips, Jan, et al.
Publicado: (2022)

Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma
por: Jalali, Shahrzad, et al.
Publicado: (2019)

P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA
por: Mochkin, N., et al.
Publicado: (2022)

Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma
por: Liu, Weiping, et al.
Publicado: (2023)

PB2259: THE NEW PD-1 INHIBITOR PROLGOLIMAB IN THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN’S LYMPHOMA
por: Semenova, Anastasia, et al.
Publicado: (2023)

PA01.03. Management of vocal cord nodule with Kanthya Gana Maha Kashaya– A case study
por: Megha, T, et al.
Publicado: (2013)

Draft Genome Sequence of Schaalia odontolytica Strain ORNL0103, a Basibiont of “Candidatus Saccharibacteria” HMT352
por: Podar, Nicholas A., et al.
Publicado: (2021)

Pseudomonas protegens FJKB0103 Isolated from Rhizosphere Exhibits Anti-Methicillin-Resistant Staphylococcus aureus Activity
por: Zhao, Hui, et al.
Publicado: (2022)

Regulation of PD-L1 Expression by NF-κB in Cancer
por: Antonangeli, Fabrizio, et al.
Publicado: (2020)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

Bob-1 is expressed in classic Hodgkin lymphoma
por: Abd El All, Howayda S
Publicado: (2007)

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma
por: Relecom, Allan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1o1qjaniuu7fku0qucgeia0eff